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Introduction
Epilepsy is one of the most common neurologi-
cal disorders in humans with a prevalence of 1% and
a lifetime incidence of 3%(1). Epilepsy can strike at
any time of life, from infancy to old age. It is charac-
terized by recurring seizures resulting from abnormal
cell firing in the brain.
It is important to distinguish the term “seizure”
from the term “epilepsy”: the last one indicates a
condition characterized by recurrent seizures due to a
chronic underlying disease.
Epilepsy varies widely in type and severity and,
today, over 50 distinct epilepsy syndromes are recog-
nized. As regards a pediatric setting, a broad range of
different epilepsy syndromes can be distinguished.
Seizure disorders can be divided into idiopathic
or symptomatic epilepsies. Symptomatic epilepsies
(approximately 30% of cases) have a clear cause,
such as metabolic disorders, brain trauma, intracra-
nial tumors, stroke or infections(2,3,4). Idiopathic
epilepsies occur in the absence of identifiable causal
factors, but recent evidence suggests that genetic fac-
tors are important in the developing of these dis-
eases. Several genes have been identified in rare
autosomal dominant and severe sporadic forms of
epilepsy, but the genetic cause is unknown in the vast
majority of cases. In proof of this, just think that
mendelian epilepsies account for only 1% of the
cases.
Some genetic syndromes can occur with
seizures or epilepsy, for example tuberous sclerosis,
neurofibromatosis, Sturge-Weber syndrome and Tay-
Sachs disease(5).
Furthermore, some epileptic syndromes have a
monogenic etiology (the disease is caused by muta-
tion of a single gene)(6,7). CHRNA4 (20q13.2-q13.3)
and CHRNB2 (1p21) genes are responsible for auto-
somal dominant nocturnal frontal lobe epilepsy.
Mutations of KCNQ2 (20q13.3) and KCNQ3 (8q24)
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genes give an inherited epilepsy of newborns. An
autosomal dominant form of juvenile myoclonic
epilepsy is due by mutation of GABRA1 gene
(5q34). All these genes encode for proteins involved
in the formation of ion channels. 
Modern research in genetics focused their atten-
tion on the role of copy number variations (CNVs),
that are submicroscopic alterations of the genome in
excess or defect (microdeletions and microduplica-
tions). CNVs are known to play an important role as
susceptibility factors for complex neurodevelopmen-
tal disorders of unknown etiology, including intellec-
tual disability (ID), autism spectrum disorders
(ASDs), and schizophrenia.
Recent studies are revealing that rare CNVs
significantly contribute even to the genetic etiology
of epilepsy.
Discussion
Several studies are increasingly recognized
CNVs as a source of phenotypic variation among
humans. The CNVs in the etiology of intellectual
disability, autism and schizophrenia have been exten-
sively investigated(8). Today the role of genomic
rearrangements in epilepsy is emerging too.
These findings were possible thanks to the
introduction of array-CGH (comparative genomic
hybridization) in the genetic researches. Array-CGH
represents the most useful method to simultaneously
detect and locate the loss or gain of genetic material.
For this reason, its application in the study of genetic
diseases is rapidly increasing.
Today we are showing that many of those
patients who, in the past, received a clinical diagno-
sis of sporadic autosomal recessive syndrome or de
novo autosomal dominant syndrome, are actually
carriers of cryptic chromosomal imbalance responsi-
ble for their condition. Many studies report that
about 15% of these patients have a cryptic chromo-
somal anomaly, detected by array-CGH with a reso-
lution of 1Mb(9,10,11,12,13).
All these conditions play an important role in
determining morbidity and mortality rates, and this is
even more important in neonatal age(14,15). Indeed, in
this age of life many other risk factors, such as con-
genital malformations, prematurity, nosocomial
infections and chemical mediators, may add their
cumulative effect influencing short- and long-term
outcome(16-30).
In the last years, array-CGH allowed the identi-
fication of many CNVs associated with mental retar-
dation, autism spectrum disorders, schizophrenia and
epilepsy. It is also important to note that CNVs can
be detected even in normal population.
The molecular genetic pathogenesis is shared
between most of these rearrangements. They are usu-
ally flanked by duplicons, or low copy repeats
(LCRs), that are blocks of few repeated sequences,
with very high mutual homology (from 90% to
100%) and large hundreds of kilobases (200-400
Kb). LCRs give to the region of DNA a high instabil-
ity and predispose to homologous recombination
events, which mediate nonallelic homologous
recombinations (NAHR) resulting in inversions,
translocations, duplications or deletions.
It’s important to underline that microdeletions
are more frequent than microduplications and they
generally result into specific and more severe signs
and symptoms, compared to the mild clinical fea-
tures due to microduplications.
Among the most important CNVs associated
with epilepsy, recent studies revealed recurrent dele-
tions at 15q11.2, 15q13.3 and 16p13.11(31). They
seem to play a role in idiopathic generalized epilep-
sies (IGEs).
An analysis of 1234 IGE patients showed that a
microdeletion at 15q11.2 is the most common
rearrangement in this cohort of patients, occurring in
1% of cases.
A 15q13.3 microdeletion syndrome has been
identified in 0.2-0.3% of individuals with mental
retardation and epilepsy, schizophrenia, autism and
other neuropsychiatric features(32,33). The critical
region of the 1.5-Mb deletion on 15q13.3 contains at
least seven genes. CHRNA7 gene, coding for the α7
subunit of the nicotinergic acetylcholine receptor, is
considered a plausible candidate gene for the epilep-
tic phenotype.
Deletions at 16p13.11 are associated with
schizophrenia, mental retardation, and most recent-
ly idiopathic generalized epilepsy. CNVs on chro-
mosome 7q34–36.1 were observed in three unrelat-
ed patients with epilepsy and schizophrenia. This
region includes CNTNAP2 gene, that has previous-
ly been associated with epilepsy. CNTNAP2
encodes Caspr2 (contactin-associated protein 2), a
member of the neurexin superfamily, a group of
transmembrane proteins that mediate cell-cell inter-
actions in the nervous system. Caspr2 is essential
for the localization of voltage-activated K+ chan-
nels in the juxtaparanodal region of axons, which
may function to stabilize conduction and help to
maintain the intermodal resting potential.
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So, a loss of function of this gene could deter-
mine an abnormal cell firing in nervous system.
A recent Italian study identified 28 rare CNVs
in 26 patients with epilepsy. Among these, we want
to mention: 22q13.32qter deletion, 19q13.43 deletion
and duplication, 6q22.31 duplication, 15q24.1 dele-
tion, 6q26qter deletion, 9q34qter deletion, 15q11-
q13 duplication and Xp22.31 deletion. Patients ana-
lyzed in this study had heterogeneous clinical fea-
tures, but genotype-phenotype correlations showed
that having mental retardation or other neuropsychi-
atric disorders in association with epilepsy was sig-
nificantly associated with the occurrence of CNVs
compared with not having them(34).
CNVs on chromosome 22q11.2, that has long
been implicated in several genomic disorders, were
also associated with epilepsy(35).
Conclusions
Modern knowledge shows the role of genetic
factors in the etiology of epilepsy. In particular,
CNVs are emerging as genetic alterations predispos-
ing to the onset of these disorders, especially when
they are associated with mental retardation or other
neuropsychiatric features.
The possibility to identify new rare CNVs
allows a greater understanding of the mechanism of
epilepsy and other neurodevelopmental disorders.
In addition, the identification of cryptic chro-
mosomal abnormalities can help to make a more
accurate genotype-phenotype correlation. It will be
possible to plan an appropriate global evaluation of
the patient and organize targeted follow-up and
therapies.
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